Table 3.
Univariate and multiple linear regression analysis for g-CFR.
| Univariable analysis | Multivariable analysis 1 | Multivariable analysis 2 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| β | 95% CI | P value | β | 95% CI | P value | β | 95% CI | P value | |
| Age, year | − 0.006 | − 0.026 to 0.013 | 0.54 | ||||||
| Male | − 0.235 | − 0.629 to 0.159 | 0.24 | ||||||
| HDL-chol, mg/dl | 0.003 | − 0.013 to 0.020 | 0.69 | ||||||
| Creatinine, mg/dl | − 1.162 | − 2.018 to − 0.306 | 0.008 | − 1.064 | − 1.873 to − 0.255 | 0.010 | − 0.917 | − 1.710 to − 0.123 | 0.024 |
| cTnI at presentation, ng/l | − 0.009 | − 0.022 to 0.004 | 0.18 | ||||||
| log (NT-proBNP), pg/ml | − 0.172 | − 0.321 to − 0.023 | 0.024 | − 0.088 | − 0.240 to 0.064 | 0.29 | − 0.152 | 0.289 to − 0.015 | 0.030 |
| CRP, mg/dl | 0.176 | − 0.142 to 0.494 | 0.28 | ||||||
| FFR | 0.624 | − 0.796 to 2.045 | 0.39 | ||||||
| Whole LV mass volume, g | − 0.009 | − 0.014 to − 0.004 | < 0.001 | ||||||
| LV mass index by CT, g/m2 | − 0.017 | − 0.026 to − 0.008 | < 0.001 | − 0.004 | − 0.014 to 0.007 | 0.50 | |||
| Area at risk mass volume, g | − 0.010 | − 0.018 to − 0.002 | 0.019 | 0 | − 0.001 to 0.008 | 0.85 | |||
| Mean PCATA | − 0.061 | − 0.090 to − 0.032 | < 0.001 | Not selected | − 0.049 | − 0.081 to − 0.016 | 0.004 | ||
| Highest PCATA | − 0.048 | − 0.074 to − 0.023 | < 0.001 | Not selected | Not selected | ||||
| Target vessel PCATA | − 0.040 | − 0.065 to − 0.014 | 0.002 | − 0.019 | − 0.047 to 0.008 | 0.17 | Not selected | ||
| EDV, ml | − 0.012 | − 0.020 to − 0.005 | 0.001 | − 0.008 | − 0.016 to 0.001 | 0.004 | − 0.008 | − 0.015 to 0.000 | 0.041 |